Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Cancer: a "stem-cell" disease?

Tu SM.

Cancer Cell Int. 2013 May 6;13(1):40. doi: 10.1186/1475-2867-13-40.

2.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
3.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
4.

Somatic stem cells and the origin of cancer.

Martínez-Climent JA, Andreu EJ, Prosper F.

Clin Transl Oncol. 2006 Sep;8(9):647-63. Review.

PMID:
17005467
5.

Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Simon DP, Hammer GD.

Mol Cell Endocrinol. 2012 Mar 31;351(1):2-11. doi: 10.1016/j.mce.2011.12.006. Epub 2012 Jan 13. Review.

6.

The role of stem cells and gap junctional intercellular communication in carcinogenesis.

Trosko JE.

J Biochem Mol Biol. 2003 Jan 31;36(1):43-8. Review.

PMID:
12542974
7.

Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?

Lathia JD, Venere M, Rao MS, Rich JN.

Stem Cell Rev. 2011 Jun;7(2):227-37. doi: 10.1007/s12015-010-9194-6. Review.

8.

Evaluating the immortal strand hypothesis in cancer stem cells: symmetric/self-renewal as the relevant surrogate marker of tumorigenicity.

Winquist RJ, Hall AB, Eustace BK, Furey BF.

Biochem Pharmacol. 2014 Sep 15;91(2):129-34. doi: 10.1016/j.bcp.2014.06.007. Epub 2014 Jun 24. Review.

PMID:
24971715
9.

Molecular events in follicular thyroid tumors.

Kroll TG.

Cancer Treat Res. 2004;122:85-105. Review.

PMID:
16209039
10.

Regulation of self-renewal in normal and cancer stem cells.

Verga Falzacappa MV, Ronchini C, Reavie LB, Pelicci PG.

FEBS J. 2012 Oct;279(19):3559-72. doi: 10.1111/j.1742-4658.2012.08727.x. Epub 2012 Aug 24. Review.

11.

Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication.

Trosko JE, Chang CC, Upham BL, Tai MH.

Ann N Y Acad Sci. 2004 Dec;1028:192-201. Review.

PMID:
15650245
12.

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Kurman RJ, Shih IeM.

Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003. Review.

13.

Nanotechnology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 1.

14.

Epigenetic gene regulation in stem cells and correlation to cancer.

Mathews LA, Crea F, Farrar WL.

Differentiation. 2009 Jul;78(1):1-17. doi: 10.1016/j.diff.2009.04.002. Epub 2009 May 14. Review.

15.

Activation of endogenous human stem cell-associated retroviruses (SCARs) and therapy-resistant phenotypes of malignant tumors.

Glinsky GV.

Cancer Lett. 2016 Jul 1;376(2):347-59. doi: 10.1016/j.canlet.2016.04.014. Epub 2016 Apr 12. Review.

PMID:
27084523
16.
17.
18.
19.

The cancer stem cell hypothesis: a guide to potential molecular targets.

Allegra A, Alonci A, Penna G, Innao V, Gerace D, Rotondo F, Musolino C.

Cancer Invest. 2014 Nov;32(9):470-95. doi: 10.3109/07357907.2014.958231. Epub 2014 Sep 25. Review.

PMID:
25254602
20.

Cancer Drug Development: New Targets for Cancer Treatment.

Curt GA.

Oncologist. 1996;1(3):II-III.

PMID:
10387987

Supplemental Content

Support Center